Literature DB >> 1537864

Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.

T Kojima1, C W Leone, G A Marchildon, J A Marcum, R D Rosenberg.   

Abstract

We have isolated heparan sulfate proteoglycans (HSPGs) from cloned rat microvascular endothelial cells using a combination of ion-exchange chromatography, affinity fractionation with antithrombin III (AT III), and gel filtration in denaturing solvents. The anticoagulantly active heparan sulfate proteoglycans (HSPGact) which bind tightly to AT III bear mainly anticoagulantly active heparan sulfate (HSact) whereas the anticoagulantly inactive heparan sulfate proteoglycans (HSPGinact) possess mainly anticoagulantly inactive heparan sulfate (HSinact). HSact and HSinact were also isolated by a combination of ion-exchange chromatography, treatment with protease and chondroitin ABC lyase, and affinity fractionation with AT III. HSact and HSinact have molecular sizes of about 25-30 kDa with the same overall composition of monosaccharides except that HSact exhibits about nine glucuronsyl 3-O-sulfated glucosamines/chain whereas HSinact possesses about three glucuronsyl 3-O-sulfated glucosamines/chain. Direct isolation of the AT III-binding site of HSact by exposing carbohydrate chains to Flavobacterium heparitinase in the presence of protease inhibitor revealed only a single interaction site which contained two to three glucuronsyl 3-O-sulfated glucosamine residues. The core proteins of HSPGact and HSPGinact were isolated by treatment with Flavobacterium heparitinase and purification by ion-exchange chromatography. The molecular sizes of the core proteins were established by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and their primary structures were examined by cleavage with trypsin or endopeptidase Glu-C as well as separation of peptides by reverse-phase high performance liquid chromatography. The results showed that both sets of core proteins exhibited three major components with molecular sizes of 50, 30, and 25 kDa, respectively. The 25-kDa species appears to be a proteolytic degradation product of the 30-kDa species. The peptide mapping revealed that HSPGact and HSPGinact possess extremely similar core proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537864

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Authors:  Thierry Charron; Nafiseh Nili; Bradley H Strauss
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

2.  Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line.

Authors:  Jennifer Y C Cheng; John Whitelock; Laura Poole-Warren
Journal:  Histochem Cell Biol       Date:  2012-08-08       Impact factor: 4.304

3.  Basement membrane and stroke.

Authors:  Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-18       Impact factor: 6.200

4.  A unique heparin-binding domain in the envelope protein of the neuropathogenic PVC-211 murine leukemia virus may contribute to its brain capillary endothelial cell tropism.

Authors:  A Jinno-Oue; M Oue; S K Ruscetti
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Heparan sulfate proteoglycans mediate factor XIIa binding to the cell surface.

Authors:  Lukasz Wujak; Miroslava Didiasova; Dariusz Zakrzewicz; Helena Frey; Liliana Schaefer; Malgorzata Wygrecka
Journal:  J Biol Chem       Date:  2015-01-14       Impact factor: 5.157

6.  Syndecan-4 as a molecule involved in defense mechanisms.

Authors:  Kazuhiro Ishiguro; Tetsuhito Kojima; Takashi Muramatsu
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 7.  Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.

Authors:  Nicholas W Shworak; Sassan HajMohammadi; Ariane I de Agostini; Robert D Rosenberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

8.  Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity.

Authors:  Ariane I de Agostini; Ji-Cui Dong; Corinne de Vantéry Arrighi; Marie-Andrée Ramus; Isabelle Dentand-Quadri; Sébastien Thalmann; Patricia Ventura; Victoria Ibecheole; Felicia Monge; Anne-Marie Fischer; Sassan HajMohammadi; Nicholas W Shworak; Lijuan Zhang; Zhenqing Zhang; Robert J Linhardt
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

9.  Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts.

Authors:  Helen M Nugent; Robert Tjin Tham Sjin; Desmond White; Luther G Milton; Roberto J Manson; Jeffrey H Lawson; Elazer R Edelman
Journal:  J Vasc Surg       Date:  2007-09       Impact factor: 4.268

Review 10.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.